1599529-23-3

Basic information

• Product Name: (3-benzyl-2,4-dimethylquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanone
• Synonyms: (3-benzyl-2,4-dimethylquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanone
• CAS NO: 1599529-23-3
• Molecular Weight: 355.439
• Mol File: 1599529-23-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3-benzyl-2,4-dimethylquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (3-benzyl-2,4-dimethylquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanone(1599529-23-3)
• EPA Substance Registry System: (3-benzyl-2,4-dimethylquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanone(1599529-23-3)

Safety Data

• Hazardous Substances Data: 1599529-23-3(Hazardous Substances Data)

Upstream product

• 15781-74-5 bis(2,4,6-trichlorophenyl)-2-benzylmalonate 
• 616-75-1 2-benzylmalonic acid 
• 1599529-22-2 3-benzyl-N-methoxy-N,2,4-trimethylquinoline-6-carboxamide 
• 71759-88-1 5-iodo-1N-methyl imidazole 
• 1599529-21-1 ethyl 3-benzyl-2,4-dimethylquinoline-6-carboxylate 
• 1599529-20-0 ethyl 3-benzyl-2,4-dibromoquinoline-6-carboxylate 
• 893767-87-8 ethyl 3-benzyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylate 

Relevant articles and documents

METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt

The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.